definiens: shall mean payments of either or both of the Trademark Royalty and the Product Royalty, as the context may require ; 1.189 shall have the meaning as defined in Section 8.2 ; 1.190 means, with respect to any Product, the period of time commencing on the date of the First Commercial Sale thereof and ending on the later o£(a ) the expiration of the Product Royalty Tenn and ( b ) the expiration of the Trademark Royalty Tenn ; 1.191 shall mean any individual who has been re ~ ined by Bradley, either directly ( e.g., a Bradley employee ) or indirectly ( e.g., an employee of another entity engaged by Bradley to render services),.to visit, and/or otherwise interface with, medical professionals in order to stimulate use and saI ~ s of Products ; 13 1.192 shall mean the second inspection, if any, performed by or on behalf of the FDA, of the ~I!l Facility in connection with the Qualification thereof ; 1.193 shall mean that Second License Agreement, effective as of~ ~,[!1 by and among ~ QMtIWJ .. ~~ and ! Mitw*1I!1, as thereafter amended~ 1.194 has the meaning ascribed thereto in Section 10.5 ; 1.195 shall mean a supplemental NDA submitted to the FDA ; 1.196 shall mean Bradley IPR or [COMPANY] IPR, as the case may be ; 1.197 shall have the meaning ascribed thereto in Section 11.13